Lisa V. Kalman

3.6k total citations · 2 hit papers
45 papers, 1.9k citations indexed

About

Lisa V. Kalman is a scholar working on Genetics, Molecular Biology and Pharmacology. According to data from OpenAlex, Lisa V. Kalman has authored 45 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 15 papers in Molecular Biology and 13 papers in Pharmacology. Recurrent topics in Lisa V. Kalman's work include Pharmacogenetics and Drug Metabolism (13 papers), Genomics and Rare Diseases (10 papers) and Bacterial Genetics and Biotechnology (7 papers). Lisa V. Kalman is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Genomics and Rare Diseases (10 papers) and Bacterial Genetics and Biotechnology (7 papers). Lisa V. Kalman collaborates with scholars based in United States, China and Netherlands. Lisa V. Kalman's co-authors include Robert P. Gunsalus, Victoria M. Pratt, Stuart A. Scott, Ira M. Lubin, Houda Hachad, Karen E. Weck, Yuan Ji, Andria L. Del Tredici, Amy S. Gargis and Andrea Gaedigk and has published in prestigious journals such as Nucleic Acids Research, Journal of Bacteriology and Journal of Clinical Microbiology.

In The Last Decade

Lisa V. Kalman

44 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trends in guideline implementation: an updated scoping review

2022 71 citations Sanne Peters, Scott C. Blanchard et al. Implementation Science profile →
2023 Australian guideline for assessing and managing cardiovascular disease risk

2024 35 citations Mark Nelson, Emily Banks et al. The Medical Journal of Australia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa V. Kalman United States	27	655	628	452	228	205	45	1.9k
Rosário Dominguez Crespo Hirata Brazil	32	831 1.3×	323 0.5×	265 0.6×	208 0.9×	229 1.1×	202	3.3k
Patrick Muller Switzerland	16	953 1.5×	211 0.3×	121 0.3×	192 0.8×	333 1.6×	44	2.7k
Hongmei Xu China	26	713 1.1×	127 0.2×	283 0.6×	131 0.6×	465 2.3×	98	2.0k
Barbara A. E. de Koning Netherlands	14	810 1.2×	374 0.6×	98 0.2×	171 0.8×	296 1.4×	29	1.8k
Shimin Zhang United States	27	641 1.0×	149 0.2×	464 1.0×	67 0.3×	98 0.5×	82	2.0k
Deborah French Italy	29	1.1k 1.7×	464 0.7×	151 0.3×	477 2.1×	155 0.8×	104	3.1k
Baruch Yerushalmi Israel	23	357 0.5×	413 0.7×	137 0.3×	135 0.6×	220 1.1×	79	1.8k
David Turgeon Canada	16	474 0.7×	196 0.3×	597 1.3×	201 0.9×	37 0.2×	22	1.4k
Knut Tore Lappegård Norway	24	689 1.1×	164 0.3×	560 1.2×	57 0.3×	840 4.1×	97	3.2k
Tony Bruns Germany	31	748 1.1×	397 0.6×	187 0.4×	56 0.2×	490 2.4×	127	3.1k

Countries citing papers authored by Lisa V. Kalman

Since Specialization

Citations

This map shows the geographic impact of Lisa V. Kalman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa V. Kalman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa V. Kalman more than expected).

Fields of papers citing papers by Lisa V. Kalman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa V. Kalman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa V. Kalman. The network helps show where Lisa V. Kalman may publish in the future.

Co-authorship network of co-authors of Lisa V. Kalman

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa V. Kalman. A scholar is included among the top collaborators of Lisa V. Kalman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa V. Kalman. Lisa V. Kalman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scheinfeldt, Laura, Dara Kusic, Andrea Gaedigk, et al.. (2025). New Resources to Identify Characterized DNA Reference Materials for Pharmacogenetic (PGx) and Human Leukocyte Antigen (HLA) Testing. Journal of Molecular Diagnostics. 27(6). 457–464.

Pratt, Victoria M., Larisa H. Cavallari, Andrea Gaedigk, et al.. (2024). DPYD Genotyping Recommendations. Journal of Molecular Diagnostics. 26(10). 851–863. 21 indexed citations

Nelson, Mark, Emily Banks, Alex Brown, et al.. (2024). 2023 Australian guideline for assessing and managing cardiovascular disease risk. The Medical Journal of Australia. 220(9). 482–490. 35 indexed citations breakdown →

Kalman, Lisa V., et al.. (2023). New Australian guideline and calculator for assessing and managing cardiovascular disease risk. Heart Lung and Circulation. 32(5). 652–652. 1 indexed citations

Gaedigk, Andrea, Erin C. Boone, Amy Turner, et al.. (2023). Characterization of Reference Materials for CYP3A4 and CYP3A5. Journal of Molecular Diagnostics. 25(9). 655–664. 8 indexed citations

Pratt, Victoria M., Larisa H. Cavallari, Andrea Gaedigk, et al.. (2023). CYP3A4 and CYP3A5 Genotyping Recommendations. Journal of Molecular Diagnostics. 25(9). 619–629. 33 indexed citations

Gaedigk, Andrea, Erin C. Boone, Steven E. Scherer, et al.. (2022). CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis. Journal of Molecular Diagnostics. 24(4). 337–350. 28 indexed citations

Pratt, Victoria M., Erin C. Boone, Ulrich Broeckel, et al.. (2022). Characterization of Reference Materials for TPMT and NUDT15. Journal of Molecular Diagnostics. 24(10). 1079–1088. 11 indexed citations

Peters, Sanne, Scott C. Blanchard, Jennifer Malinowski, et al.. (2022). Trends in guideline implementation: an updated scoping review. Implementation Science. 17(1). 50–50. 71 indexed citations breakdown →

10.

Pratt, Victoria M., Amy Turner, Ulrich Broeckel, et al.. (2021). Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX. Journal of Molecular Diagnostics. 23(8). 952–958. 11 indexed citations

11.

Pratt, Victoria M., Larisa H. Cavallari, Andria L. Del Tredici, et al.. (2021). Recommendations for Clinical CYP2D6 Genotyping Allele Selection. Journal of Molecular Diagnostics. 23(9). 1047–1064. 97 indexed citations

12.

Gaedigk, Andrea, Amy Turner, Robin E. Everts, et al.. (2019). Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles. Journal of Molecular Diagnostics. 21(6). 1034–1052. 54 indexed citations

13.

Pratt, Victoria M., Andria L. Del Tredici, Houda Hachad, et al.. (2018). Recommendations for Clinical CYP2C19 Genotyping Allele Selection. Journal of Molecular Diagnostics. 20(3). 269–276. 141 indexed citations

14.

Kalman, Lisa V., Vivekananda Datta, Mickey Williams, et al.. (2016). Development and Characterization of Reference Materials for Genetic Testing: Focus on Public Partnerships. Annals of Laboratory Medicine. 36(6). 513–520. 15 indexed citations

15.

Kalman, Lisa V., Jack Tarleton, Madhuri Hegde, et al.. (2013). Development of a Genomic DNA Reference Material Panel for Myotonic Dystrophy Type 1 (DM1) Genetic Testing. Journal of Molecular Diagnostics. 15(4). 518–525. 14 indexed citations

16.

Kalman, Lisa V., Jay Leonard, Norman P. Gerry, et al.. (2011). Quality Assurance for Duchenne and Becker Muscular Dystrophy Genetic Testing. Journal of Molecular Diagnostics. 13(2). 167–174. 18 indexed citations

17.

Kalman, Lisa V., Jean Amos Wilson, Arlene Buller, et al.. (2009). Development of Genomic DNA Reference Materials for Genetic Testing of Disorders Common in People of Ashkenazi Jewish Descent. Journal of Molecular Diagnostics. 11(6). 530–536. 7 indexed citations

18.

Kalman, Lisa V., Monique Johnson, Jeanne C. Beck, et al.. (2007). Development of genomic reference materials for Huntington disease genetic testing. Genetics in Medicine. 9(10). 719–723. 16 indexed citations

19.

Anyanful, Akwasi, et al.. (2005). Paralysis and killing of Caenorhabditis elegans by enteropathogenic Escherichia coli requires the bacterial tryptophanase gene. Molecular Microbiology. 57(4). 988–1007. 128 indexed citations

20.

Gunsalus, Robert P., et al.. (1989). Nucleotide sequence of thenarLgene that is involved in global regulation of nitrate controlled respiratory genes ofEscherichia coli. Nucleic Acids Research. 17(5). 1965–1975. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact